2-Year patient-related versus stent-related outcomes: The SORT OUT IV (scandinavian organization for randomized trials with clinical outcome IV) trial

Journal of the American College of Cardiology

Volumn 60, Issue 13, 2012, Pages 1140-1147

  Jensen, Lisette Okkels ^a   Thayssen, Per ^a   Christiansen, Evald Hoj ^b   Tilsted, Hans Henrik ^c   Maeng, Michael ^b   Hansen, Knud Norregaard ^a   Kaltoft, Anne ^b   Hansen, Henrik Steen ^a   Botker, Hans Erik ^b   Krusell, Lars Romer ^a   Ravkilde, Jan ^c   Madsen, Morten ^b   Thuesen, Leif ^b   Lassen, Jens Flensted ^b  

^a ODENSE UNIVERSITY HOSPITAL   (Denmark)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

drug eluting stent; outcome; percutaneous coronary intervention

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; EVEROLIMUS; PACLITAXEL; RAPAMYCIN; ZOTAROLIMUS;

ANGIOCARDIOGRAPHY; ARTICLE; BARE METAL STENT; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DRUG ELUTING STENT; HEART DEATH; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; STABLE ANGINA PECTORIS; STENT THROMBOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CORONARY ARTERY DISEASE; DEATH; DENMARK; DRUG-ELUTING STENTS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; SINGLE-BLIND METHOD; SIROLIMUS; THROMBOSIS; TREATMENT OUTCOME;

EID: 84866418436     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2012.07.004     Document Type: Article

References (16)

1. J.W. Moses, M.B. Leon, J.J. Popma Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery N Engl J Med 349 2003 1315 1323
2. L.O. Jensen, H.H. Tilsted, P. Thayssen Paclitaxel and sirolimus eluting stents versus bare metal stents: long-term risk of stent thrombosis and other outcomes From the Western Denmark Heart Registry EuroIntervention 5 2010 898 905
3. K. Rasmussen, M. Maeng, A. Kaltoft Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial Lancet 375 2010 1090 1099
4. G.W. Stone, A. Rizvi, K. Sudhir Randomized comparison of everolimus- and paclitaxel-eluting stents: 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial J Am Coll Cardiol 58 2011 19 25
5. R.A. Byrne, A. Kastrati, S. Kufner Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) trial Eur Heart J 30 2009 2441 2449
6. P.C. Smits, E. Kedhi, K.J. Royaards 2-year follow-up of a randomized controlled trial of everolimus- and paclitaxel-eluting stents for coronary revascularization in daily practice COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTE stent in all-comers: a randomized open label trial) J Am Coll Cardiol 58 2011 11 18
7. S. Silber, S. Windecker, P. Vranckx, P.W. Serruys Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial Lancet 377 2011 1241 1247
8. G.G. Stefanini, B. Kalesan, P.W. Serruys Long-term clinical outcomes of biodegradable polymer biolimus-eluting stents versus durable polymer sirolimus-eluting stents in patients with coronary artery disease (LEADERS): 4 year follow-up of a randomised non-inferiority trial Lancet 378 2011 1940 1948
9. L.O. Jensen, P. Thayssen, H.S. Hansen Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials With Clinical Outcome IV (SORT OUT IV) Circulation 125 2012 1246 1255
10. D.E. Cutlip, S. Windecker, R. Mehran Clinical end points in coronary stent trials: a case for standardized definitions Circulation 115 2007 2344 2351
11. L.O. Jensen, M. Maeng, A. Kaltoft Stent thrombosis, myocardial infarction, and death after drug-eluting and bare-metal stent coronary interventions J Am Coll Cardiol 50 2007 463 470
12. T.F. Andersen, M. Madsen, J. Jorgensen, L. Mellemkjoer, J.H. Olsen The Danish National Hospital Register: a valuable source of data for modern health sciences Dan Med Bull 46 1999 263 268
13. T.A. Gooley, W. Leisenring, J. Crowley, B.E. Storer Estimation of failure probabilities in the presence of competing risks: new representations of old estimators Stat Med 18 1999 695 706
14. R.A. Byrne, A. Kastrati, S. Massberg Biodegradable polymer versus permanent polymer drug-eluting stents and everolimus- versus sirolimus-eluting stents in patients with coronary artery disease: 3-year outcomes from a randomized clinical trial J Am Coll Cardiol 58 2011 1325 1331
15. K.W. Park, I.H. Chae, D.S. Lim Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial J Am Coll Cardiol 58 2011 1844 1854
16. M.J. Zellweger, C. Kaiser, R. Jeger Coronary artery disease progression late after successful stent implantation J Am Coll Cardiol 59 2012 793 799